LBA-004Novel carcinoembryonic antigen T-cell bispecific (CEA-TCB) antibody: Preliminary clinical data as a single agent and in combination with atezolizumab in patients with metastatic colorectal cancer (mCRC)
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Argiles, Guillem
- dc.contributor.author Albanell Mestres, Joan
- dc.contributor.author Tabernero Cartula, Josep
- dc.date.accessioned 2019-02-28T08:31:49Z
- dc.date.available 2019-02-28T08:31:49Z
- dc.date.issued 2017
- dc.format.mimetype application/pdf
- dc.identifier.citation Argilés G, Saro J, Segal NH, Melero I, Ros W, Marabelle A. et al. LBA-004Novel carcinoembryonic antigen T-cell bispecific (CEA-TCB) antibody: Preliminary clinical data as a single agent and in combination with atezolizumab in patients with metastatic colorectal cancer (mCRC). Ann Oncol. 2017 Jun 1;28(Suppl 3):151. DOI: 10.1093/annonc/mdx302.003
- dc.identifier.doi http://dx.doi.org/10.1093/annonc/mdx302.003
- dc.identifier.issn 0923-7534
- dc.identifier.uri http://hdl.handle.net/10230/36688
- dc.language.iso eng
- dc.publisher Oxford University Press
- dc.relation.ispartof Annals of Oncology. 2017 Jun 1;28(Suppl 3):151
- dc.rights © Oxford University Press. This is a pre-copyedited, author-produced version of an article accepted for publication in Annals of oncology following peer review. The version of record [Argilés G, Saro J, Segal NH, Melero I, Ros W, Marabelle A. et al. LBA-004Novel carcinoembryonic antigen T-cell bispecific (CEA-TCB) antibody: Preliminary clinical data as a single agent and in combination with atezolizumab in patients with metastatic colorectal cancer (mCRC). Ann Oncol. 2017 Jun 1;28(suppl_3) is available online at: https://academic.oup.com/annonc/article/28/suppl_3/mdx302.003/3916891. DOI: 10.1093/annonc/mdx302.003
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.subject.other Còlon -- Càncer -- Aspectes genètics
- dc.title LBA-004Novel carcinoembryonic antigen T-cell bispecific (CEA-TCB) antibody: Preliminary clinical data as a single agent and in combination with atezolizumab in patients with metastatic colorectal cancer (mCRC)
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/publishedVersion